MARZO, TIZIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.366
EU - Europa 2.621
AS - Asia 1.644
SA - Sud America 278
AF - Africa 45
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.321
RU - Federazione Russa 901
PL - Polonia 522
SG - Singapore 445
IT - Italia 368
CN - Cina 365
HK - Hong Kong 261
IE - Irlanda 231
BR - Brasile 223
VN - Vietnam 218
SE - Svezia 127
KR - Corea 117
FI - Finlandia 101
NL - Olanda 76
DE - Germania 74
GB - Regno Unito 68
FR - Francia 66
IN - India 59
JO - Giordania 43
ID - Indonesia 31
CA - Canada 24
AR - Argentina 23
JP - Giappone 21
UA - Ucraina 20
AU - Australia 19
ES - Italia 18
TR - Turchia 16
BD - Bangladesh 15
MX - Messico 15
BE - Belgio 13
CH - Svizzera 13
ZA - Sudafrica 11
IQ - Iraq 10
CI - Costa d'Avorio 9
CO - Colombia 8
NG - Nigeria 8
EC - Ecuador 7
UZ - Uzbekistan 6
BG - Bulgaria 5
MA - Marocco 5
PK - Pakistan 5
AT - Austria 4
AZ - Azerbaigian 4
CL - Cile 4
PE - Perù 4
PH - Filippine 4
SA - Arabia Saudita 4
TN - Tunisia 4
VE - Venezuela 4
XK - ???statistics.table.value.countryCode.XK??? 4
IL - Israele 3
PY - Paraguay 3
RO - Romania 3
AL - Albania 2
BB - Barbados 2
CZ - Repubblica Ceca 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
NP - Nepal 1
OM - Oman 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TG - Togo 1
VI - Stati Uniti Isole Vergini 1
Totale 9.978
Salva come PNG Salva come JPEG
Città #
Santa Clara 990
Ashburn 585
Warsaw 521
Fairfield 505
Singapore 312
Chandler 250
Woodbridge 245
Dublin 231
Seattle 213
Hong Kong 211
Houston 192
Cambridge 182
Wilmington 156
San Jose 130
Ann Arbor 120
Seoul 116
Beijing 112
Florence 108
Lawrence 89
Altamura 87
Amsterdam 70
New York 70
Princeton 68
Ho Chi Minh City 66
Council Bluffs 58
Buffalo 53
Hanoi 52
Moscow 52
Los Angeles 49
Boston 47
The Dalles 45
Lauterbourg 43
Helsinki 42
Munich 40
Clifton 37
Mumbai 32
Turku 32
Dallas 26
Shanghai 25
Medford 24
Jakarta 19
Melbourne 18
San Diego 18
Boardman 16
Hefei 16
London 16
Tokyo 16
Brussels 13
São Paulo 13
Chicago 12
Orem 12
Barcelona 11
Redondo Beach 11
Bern 10
Haiphong 10
Kent 10
Paris 10
Toronto 10
Abidjan 9
Brooklyn 9
Dong Ket 9
Rio de Janeiro 9
Abuja 8
Da Nang 8
Jacksonville 8
Milan 8
Serra 8
Falls Church 7
Manchester 7
Norwalk 7
Rome 7
Tianjin 7
Yubileyny 7
Atlanta 6
Baghdad 6
Charlotte 6
Frankfurt am Main 6
Miano 6
Montreal 6
Phoenix 6
Porto Alegre 6
San Francisco 6
Stockholm 6
Tashkent 6
Biên Hòa 5
Chennai 5
Denver 5
Hillsboro 5
Johannesburg 5
Lappeenranta 5
Lấp Vò 5
New Delhi 5
Pisa 5
Salt Lake City 5
Sofia 5
Thái Bình 5
Baku 4
Belo Horizonte 4
Cagliari 4
Curitiba 4
Totale 6.787
Salva come PNG Salva come JPEG
Nome #
The leading established metal-based drugs: a revisitation of their relevant physico-chemical data 656
FROM CONVENTIONAL TO NOVEL Pt-BASED ANTINEOPLASTIC AGENTS: MECHANISTIC ASPECTS AND BIOLOGICAL EFFECTS 365
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 338
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 330
A Fluorescent Silver(I) Carbene Complex with Anticancer Properties: Synthesis, Characterization, and Biological Studies 326
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 309
Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes 304
Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study 259
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 244
PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features 239
Auranofin and its Analogues Show Potent Antimicrobial Activity Covering Multiresistant Pathogens: Structure-Activity Relationships 224
The combined activation of K Ca 3.1 and inhibition of K v 11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells 217
Chlorido and bromido oxaliplatin analogues as potential agents for CRC treatment: Solution behavior, protein binding and cytotoxicity evaluation 201
Diruthenium Diacetate-Catalyzed Aerobic Oxidation of Hydroxylamines and Improved Chemoselectivity by Immobilization to Lysozyme 193
Elucidating the reactivity of Pt(II) complexes with (O,S) bidentate ligands towards DNA model systems 189
Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles 189
Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies 187
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 185
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 179
Synthesis, characterization and DNA interactions of [Pt3(TPymT)Cl3], the trinuclear platinum(II) complex of the TPymT ligand 175
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 174
ESI-MS studies of the reactions of novel platinum(II) complexes containing O,O'-chelated acetylacetonate and sulfur ligands with selected model proteins 173
cis-Pt I2(NH3)2: a reappraisal 172
Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin 172
Cytotoxic activity and protein binding through an unusual oxidative mechanism by an iridium(I)–NHC complex 171
Interaction of anticancer Ru(III) complexes with single stranded and duplex DNA model systems 171
Protein Metalation by Anticancer Metallodrugs: A Joint ESI MS and XRD Investigative Strategy 170
Oxaliplatin vs. cisplatin: Competition experiments on their binding to lysozyme 170
Reaction with proteins of a five-coordinate platinum(II) compound 169
Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections 158
Interaction of a gold(i) dicarbene anticancer drug with human telomeric DNA G-quadruplex: solution and computationally aided X-ray diffraction analysis 151
The cisplatin/serum albumin system: A reappraisal 145
Interplay of crystallography, Raman microspectroscopy and electrospray mass spectrometry for studying the reaction between ruthenium complexes and proteins 140
Reactions of Cytotoxic Metallodrugs with Lysozyme in pure DMSO explored through UV-Vis Absorption Spectroscopy and ESI MS 138
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 137
Synthesis and Mode of Action Studies on Iridium(I)–NHC Anticancer Drug Candidates 137
Interactions between Anticancertrans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts oftrans-(Dimethylamino)(methylamino)dichloridoplatinum(II) 130
Ruthenium(II) 1,4,7-trithiacyclononane complexes of curcumin and bisdemethoxycurcumin: Synthesis, characterization, and biological activity 129
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 124
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 124
Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study 122
On the Different Mode of Action of Au(I)/Ag(I)-NHC Bis-Anthracenyl Complexes Towards Selected Target Biomolecules 120
Description of a Non-Canonical AsPt Blue Species Originating from the Aerobic Oxidation of AP-1 in Aqueous Solution 119
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 119
The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme 118
Mechanistic studies on cytotoxic gold compounds 118
Peculiar Features in the Crystal Structure of the Adduct Formed betweencis-PtI2(NH3)2and Hen Egg White Lysozyme 116
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study 115
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 113
Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts 110
A Role for Metal-Based Drugs in Fighting COVID-19 Infection? The Case of Auranofin 110
In vitro anti-sars-cov-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study 109
Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis 108
Unusual Structural Features in the Lysozyme Derivative of the Tetrakis(acetato)chloridodiruthenium(II,III) Complex 106
null 47
null 31
The impact of albumin conjugation on the cytotoxic properties of cisplatin, oxaliplatin and auranofin in cancer cells 21
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 16
Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study (2022) Inorganic Chemistry 11
null 2
Totale 10.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202132 0 0 0 0 0 0 0 0 0 0 0 32
2021/2022403 5 25 32 13 28 16 11 48 28 25 52 120
2022/20231.056 101 254 44 77 61 175 144 50 93 7 24 26
2023/2024412 16 32 64 10 21 91 24 95 9 19 13 18
2024/20252.533 86 275 155 380 804 428 34 77 57 56 104 77
2025/20263.028 279 362 175 290 306 116 344 126 264 201 522 43
Totale 10.095